India's drug regulator, the Central Drug Standards Control Organization, operates with a skeletal staff and laxer regulations than the American Food and Drug Administration. This could explain why so many Indian generics makers are facing restrictions on exporting to the USA, but continue to manufacture drugs with no bar in India.
This does not necessarily mean all Indian drugs are unsafe. What it does mean is that the risk of adulteration and poor quality is higher, but will often go undetected.
Click here to read my article on the subject in Forbes India: http://forbesindia.com/article/real-issue/doctors-dilemma-to-prescribe-or-not-to-prescribe/38132/1
No comments:
Post a Comment